Boryung Pharm (003850) — Capital Reinvestment Ratio
Latest as of September 2025:
0.10x
Boryung Pharm (003850) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩48.95 Billion) in capital expenditures (₩4.92 Billion). See Boryung Pharm free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
₩48.95 Billion
KRW
Capital Expenditures
₩4.92 Billion
KRW
Data as of
Sep 2025
Most recent filing
Boryung Pharm Capital Reinvestment Ratio (2009–2024)
This chart tracks Boryung Pharm's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Boryung Pharm (2009–2024)
Year-by-year Capital Reinvestment Ratio for Boryung Pharm from 2009 to 2024. For live market cap and broader valuation context, see how much is Boryung Pharm worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩80.56 Billion | ₩20.05 Billion | ▼ -55.0% |
| 2023 | 0.55x | ₩42.22 Billion | ₩23.35 Billion | ▼ -24.1% |
| 2022 | 0.73x | ₩27.81 Billion | ₩20.28 Billion | ▲ +171.9% |
| 2021 | 0.27x | ₩60.17 Billion | ₩16.13 Billion | ▼ -34.3% |
| 2020 | 0.41x | ₩44.74 Billion | ₩18.27 Billion | ▼ -71.4% |
| 2019 | 1.43x | ₩47.00 Billion | ₩67.02 Billion | ▲ +1.2% |
| 2018 | 1.41x | ₩38.91 Billion | ₩54.83 Billion | ▼ -50.8% |
| 2016 | 2.87x | ₩9.36 Billion | ₩26.83 Billion | ▲ +427.9% |
| 2012 | 0.54x | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩9.19 Billion | ₩14.16 Billion | ▲ +24.9% |
| 2010 | 1.23x | ₩24.12 Billion | ₩29.77 Billion | ▼ -60.7% |
| 2009 | 3.14x | ₩3.59 Billion | ₩11.28 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow